US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Shooting injures 2 at Missouri high school graduation ceremony
CAPE GIRARDEAU, Mo. (AP) — Two people were injured when gunfire broke out during a high school gradu2024-05-21Chinese vice premier calls for rule of data for sustainable development
(Xinhua) 10:22, April 25, 2023Chinese Vice Premier Ding Xuexiang, also a member of the Standing Comm2024-05-21Chinese premier calls for better communication, exchanges among international community
(Xinhua) 10:46, June 27, 2023TIANJIN, June 27 (Xinhua) -- Chinese Premier Li Qiang called for better2024-05-21State Council stresses work on flood relief, rebuilding
By HOU LIQIANG (Chinadaily.com.cn) 16:00, August 09, 2023The State Council, China's Cabinet, has str2024-05-21French sports minister calls for sanctions after Monaco player tapes over anti
PARIS (AP) — France’s sports minister has called for soccer club Monaco to be sanctioned after one o2024-05-21Josh Bell homers, Max Meyer fans career
MIAMI (AP) — Josh Bell homered, Max Meyer allowed one run over six innings, and the Miami Marlins be2024-05-21
atest comment